Also, silencing of Prx II in AML blasts stimulates interleukin 3 (IL-3) cytokines, thereby increasing the phosphorylation of MAP kinase to induce downstream signaling pathways including ERK signaling. Here, IL3 is linked to acute myeloid leukemia.